Journal of Alzheimers Disease & Parkinsonism
Open Access

Investigating Basal Autophagic Activity in Brain Regions Associated with Neurodegeneration using In Vivo and Ex Vivo Models

Chrisna Swart, Akile Khoza, Khaalid Khan, Stefan Le Roux, Anton du Plessis and Ben Loos

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:337

DOI: 10.4172/2161-0460.1000337

Peptides Derived from Neuronal Cell Cycle like Kinase 5 Activator p35, in Neurodegeneration; Pathology and Therapy

Philip Grant, Manju Bhaskar, Binukumar BK and Harish C Pant

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:338

DOI: 10.4172/2161-0460.1000338

Role of the Transcription Factor Nrf2 in Parkinson's Disease: New Insights

Isabel Lastres-Becker

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:340

DOI: 10.4172/2161-0460.1000340

Synaptic Function and Dysfunction in Alzheimer's Disease

Origlia N and Domenici L

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:341

DOI: 10.4172/2161-0460.1000341

The Prevention of Alzheimer's Disease and Parkinson's Disease by Monascus purpureus NTU 568-Fermented Compounds

Chun Lin Lee and Tzu Ming Pan

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:342

DOI: 10.4172/2161-0460.1000342

Huntington's Disease: Unique Problems or Similar Impact to Other Degenerative Neurological Disorders?

Steve Smith

Short Communication: J Alzheimers Dis Parkinsonism 2017, 7:343

DOI: 10.4172/2161-0460.1000343

New Insight into Alzheimer's Disease via Caspase 3-cleaved Tau: Pathogenic Role in Tau Oligomer Formation and Memory Deficits

Young Doo Kima, Jisu Parka and Yong Keun Jung

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:344

DOI: 10.4172/2161-0460.1000344

Urine Formaldehyde: A Non-Invasive Marker for Alzheimer's Disease?

Zhiqian Tong

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:345

DOI: 10.4172/2161-0460.1000345

Ethnic Differences in Early Onset Alzheimer's Disease

Huei-Yang Chen and Peter K Panegyres

Commentary: J Alzheimers Dis Parkinsonism 2017, 7:346

DOI: 10.4172/2161-0460.1000346

United Nations and World Health Organisation Engagement in Treating Global Mental Health, with a Special Focus on Dementia

Daniela Fisichella

Conference Proceeding: J Alzheimers Dis Parkinsonism 2017, 7:347

DOI: 10.4172/2161-0460.1000347

Protein Gelation around Axons Inhibits Action Potential Propagation in Nerve Fibers

Wade N Dauberman, Samuel Breit and Shaohua Xu

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:349

DOI: 10.4172/2161-0460.1000349

Ophthalmic Artery Flow and Cognitive Performance in Patients with Carotid Artery Stenosis

Kuo Lun Huang, Meng Yang Ho and Tsong-Hai Lee

Mini Review: J Alzheimers Dis Parkinsonism 2017, 7:350

DOI: 10.4172/2161-0460.1000350

Exploring the Genetic Architecture of Parkinson's Disease in a Southern Spanish Population

Sara Bandrés Ciga, Clara Ruz, Francisco J Barrero, Francisco Escamilla Sevilla, Javier Pelegrina, Manuel Ramirez, Francisco Vives and Raquel Duran

Commentary: J Alzheimers Dis Parkinsonism 2017, 7:351

DOI: 10.4172/2161-0460.1000351

Citicoline as Add-On Treatment in Alzheimer's Disease: Tips from the Citicholinage Study

Pietro Gareri and Alberto Castagna

Short Communication: J Alzheimers Dis Parkinsonism 2017, 7:353

DOI: 10.4172/2161-0460.1000353

Botulinum Toxin Type A and Physiokinesiterapy in the Treatment of Pisa Syndrome

Marvulli R, Mastromauro L, Falcicchio ML, Gallo GA, Napolitano M, Schivardi E, Fiore P, Megna M and Ianieri G

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:354

DOI: 10.4172/2161-0460.1000354

Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function

Holly NC, Brian WK, Kara L Hamilton N, Sophie R, Martin AK, Patrice LW, James MJ, Jeffery MV, Michael LC, Regina MC, John RG, Lindsay AF, Eden RM, Gary WB, Jonathan LH and Margaret A Pericak V

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:355

DOI: 10.4172/2161-0460.1000355

Efficacy of Incobotulinumtoxin Type A (Xeomin^®) in the Management of Sialorrhea in Neurodegenerative Diseases

Marvulli R, Mastromauro L, De Venuto G, Napolitano M, Falcicchio M, Gallo GA, Schivardi E, Fiore P, Megna M and Ianieri G

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:356

DOI: 10.4172/2161-0460.1000356

Comparative Analysis of Nasal Therapy with Soluble and Liposomal Forms of Curcumin on Rats with Alzheimer’s Disease Model

Sokolik VV, Berchenko OG and Shulga SM

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:357

DOI: 10.4172/2161-0460.1000357

Identification of Serum Anti-GADD34 Antibody as a Common Marker of Diabetes Mellitus and Parkinson Disease

Kazuo S, Tomiyoshi G, Masahiro M, Satoshi K, Shigeki H, Setsu S, Minako B, Mayumi M, Akiyuki U, Kenichiro K, Minoru T, Akiko H, Masashi Y, Kazuki K, Harukiyo K, Ryoichi I, Koutaro Y, Seiichiro M, Toshio M, Eiichi K, Yoichi Y, Tomoo M, Yasuo I, Yoshio K, Rika N, Natsuko S, Hideyuki K, Hao W, Xiao-Meng Z and Takaki H

Research Article: J Alzheimers Dis Parkinsonism 2017, 7:358

DOI: 10.4172/2161-0460.1000358

Alzheimer's Disease Pathogenesis: The Denied Access Model

Wade ND and Shaohua X

Review Article: J Alzheimers Dis Parkinsonism 2017, 7:359

DOI: 10.4172/2161-0460.1000359

Effect GPi Stimulation on Human Thalamic Neuronal Activity: A Decade Later

Etienne Pralong

Commentary: J Alzheimers Dis Parkinsonism 2017, 7:360

DOI: 10.4172/2161-0460.1000360

The Mild Cognitive Impairment (MCI) in Searching for its Clinical Identity, Comment of the NEDICES Cohort Data

Félix Bermejo P

Short Communication: J Alzheimers Dis Parkinsonism 2017, 7:361

DOI: 10.4172/2161-0460.1000361